ABBOTT LABORATORIES holding history
As of Nov. 6, 2026 (UTC)
| March 31, 2025 | 1,365,785 | $181,171,380 | 2.00% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 9, 2025 |
| June 30, 2025 | 2,378,563 | $323,508,354 | 3.79% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Aug. 8, 2025 |
| Sept. 30, 2025 | 2,409,429 | $322,718,920 | 4.00% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Nov. 6, 2025 |
| Dec. 31, 2025 | 1,873,063 | $234,676,063 | 3.69% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Feb. 11, 2026 |
| March 31, 2026 | 1,486,036 | $152,571,316 | 3.01% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 5, 2026 |
| June 30, 2026 | 885,262 | $80,328,674 | 1.95% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Aug. 7, 2026 |
6 rows · Sort by column; scroll horizontally for more.
No rows match these filters.
Schedule 13G disclosures
No verified related disclosures are included in this freeze.
About reported holdings
13F reports quarter-end securities, excluding cash and shorts. Position changes do not establish trades, motives or returns; portfolio weights use disclosed 13F value.